COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. L'invention concerne des composés thérapeutiques représentés par la formule (I),...

Full description

Saved in:
Bibliographic Details
Main Authors KRULLE, THOMAS, MARTIN, STEWART, ALAN, JOHN, WILLIAM, STONEHOUSE, DAVID, FRENCH, DUPREE, TOM, BANKSIA, SCHOFIELD, KAREN, LESLEY, FRY, PETER, TIMOTHY, STAROSKE, THOMAS, FYFE, MATTHEW, COLIN, THOR, JEEVARATNAM, REVATHY, PERPETUA, WITHALL, DAVID, MATTHEW, SMYTH, DONALD, BARBA, OSCAR, SWAIN, SIMON, ANDREW
Format Patent
LanguageEnglish
French
Published 16.09.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to therapeutic compounds of the following formula (I) which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. L'invention concerne des composés thérapeutiques représentés par la formule (I), qui présentent une activité d'agonistes de GPR119 et sont utiles pour traiter des troubles métaboliques, y compris le diabète de type 2.
Bibliography:Application Number: WO2010GB50441